Papadimitriou C, Roots A, Koenigsmann M, Oelmann E, Topp M, Oberberg D, Reufi B, Thiel E, Berdel W
FREE UNIV BERLIN,UNIVKLINIKUM BENJAMIN FRANKLIN,ABT INNERE MED SCHWERPUNKT HAMATOL & ONKOL,D-12200 BERLIN,GERMANY.
Int J Oncol. 1996 Dec;9(6):1107-12. doi: 10.3892/ijo.9.6.1107.
Immunomagnetic separation using anti-CD34 monoclonal antibodies and paramagnetic microspheres has been used to enrich hematopoietic stem cells from human bone marrow, whole cord blood, or mobilized peripheral blood mononuclear cell collections. This method has been reported to achieve high separation purity of CD34+ cells in small scale experiments with fresh material. The aim of the present study was to compare the efficacy of the CD34+ cell selection technique, when thawed bone marrow or fresh peripheral blood mononuclear cells were enriched. Starting with thawed bone marrow containing 2.9% CD34+ cells the final product purity was 67.7% with a 6% CD34+ cell yield (enrichment factor 25.7), and a 85-fold CFU-GM enrichment. Using fresh mobilized peripheral blood mononuclear cells the released cells contained 77.6% CD34+ cells with a 47% yield (enrichment 86.5-fold), and a 46-fold CFU-GM enrichment. These results indicate that CD34+ cells can be selected from cryopreserved bone marrow using immunomagnetic procedures. However, fresh leukapheresis products seem to be a much better material for a positive immunomagnetic stem cell selection technique in terms of purity, yield and enrichment.
使用抗CD34单克隆抗体和顺磁性微球的免疫磁珠分离法已被用于从人骨髓、全脐带血或动员的外周血单个核细胞采集中富集造血干细胞。据报道,该方法在小规模新鲜样本实验中可实现CD34+细胞的高分离纯度。本研究的目的是比较在富集解冻骨髓或新鲜外周血单个核细胞时,CD34+细胞选择技术的效果。从含有2.9% CD34+细胞的解冻骨髓开始,最终产物纯度为67.7%,CD34+细胞产率为6%(富集因子25.7),CFU-GM富集85倍。使用新鲜的动员外周血单个核细胞,释放的细胞中含有77.6%的CD34+细胞,产率为47%(富集86.5倍),CFU-GM富集46倍。这些结果表明,可以使用免疫磁珠程序从冷冻保存的骨髓中选择CD34+细胞。然而,就纯度、产率和富集而言,新鲜的白细胞分离产品似乎是免疫磁珠阳性干细胞选择技术的更好材料。